Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Kedudukan dalam Saham #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Harga Saham
$0.52468396
Modal Pasaran
$37.85M
Perubahan (1 hari)
1.23%
Perubahan (1 tahun)
-4.53%
Negara
TW
Perdagangan Enimmune corporation (6564)

Kategori

Nisbah P/S bagi Enimmune corporation (6564)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Enimmune corporation, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Enimmune corporation dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH